However, other circulating and resident vascular cell types have also been described to produce 2-AG and might account for an increase in 2-AG during myocardial infarction: first, platelets have been described to release 2-AG upon treatment with platelet-activating factor (PAF) [22]. This evidence concerns the gene PCLAF and myocardial infarction.